SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-050965
Filing Date
2023-02-27
Accepted
2023-02-27 17:09:37
Documents
16
Period of Report
2023-02-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d448993d8k.htm   iXBRL 8-K 28646
2 EX-1.1 d448993dex11.htm EX-1.1 19882
3 EX-5.1 d448993dex51.htm EX-5.1 9371
7 GRAPHIC g448993g0227232716189.jpg GRAPHIC 2412
8 GRAPHIC g448993g0227233225774.jpg GRAPHIC 2554
  Complete submission text file 0001193125-23-050965.txt   198321

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pcvx-20230227.xsd EX-101.SCH 2850
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pcvx-20230227_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pcvx-20230227_pre.xml EX-101.PRE 11261
10 EXTRACTED XBRL INSTANCE DOCUMENT d448993d8k_htm.xml XML 3341
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39323 | Film No.: 23676490
SIC: 2836 Biological Products, (No Diagnostic Substances)